These Three Toilets Detection Health Technologies Will Be Clinically Tested In The US, Israel And Japan
Israeli digital health startup OutSense has been awarded a number of patents for key innovations in IoT technology, according to foreign media reports on 23 June. The technology gains life-saving medical insights by analysing human excrement. Le compañía ts'o'ok u presentado jump'éel serie óoxp'éel patentes ba'ax ku pixiko'ob elementos u sensor inodoro médico.
Three Toilets Detection Health Technologies
The first OutSense toilets detection health technologies is for the detection of blood hidden in the toilet bowl. This OutSense device uses reflected light from the toilet to determine the optical signature of hidden blood in faeces. Patents for this technology have been granted in the US, Europa, Japón ka China.
A second toilets detection health technologies has been granted in Europe and applications for this patent are pending in other countries. It allows effective analysis of the many components of faeces and the spatial distribution of blood traces. On the basis of this analysis, Le ma'alo'obtal OutSense je'el u páajtal u identificar le fuente k'i'ik'el a lo largo de le tracto gastrointestinal.
A third patent is pending for a technology that detects the dehydrated composition of urine through the analysis of urine and faeces.
Bin u CEO OutSense ti', Yfat Scialom, who predicts that “yéetel u explosión le ts'aako' digital, this kind of monitoring will become the norm”, OutSense says that the technology already approved and pending approval will provide broad protection for a person’s health by non-invasively extracting faeces and hidden blood from the urine. Hidden blood is essential for detecting colorectal cancer, K'oja'anil inflamatoria intestinal yéetel infecciones le tracto urinario.
Its solution consists of a multispectral optical sensor, jump'éel fuente sáasil yéetel juntúul dispositivo detección autónomo ku analte'obo' yaan jump'éel conexión WiFi. The device scans human excrement, identifies the optical footprint of faecal and urine components, sends the data to an AI-based cloud analysis and then provides indications of various diseases with great precision.
OutSense has developed tools to diagnose abnormalities in human excreta. A'alajil t'aan obtenida u muestras u k'i'ik'el, combinado yéetel juntúul análisis adicional ti' le k'iin tak le sangrado tak le excreción, Proporciona detalles le patología hemorrágica. Its specific patterns can determine whether the bleeding is from a fissure or haemorrhoid, from a polyp, a tumour or from an ulcer.
At the beginning of June, OutSense anunció u CommuniCare, Nojoch empresa tu láakal yéetel asab ti' 90 healthcare facilities in the US, comenzará probar u ma'alo'obtal le ja'aba'. Beyxan ti' kaambalilo'ob le piloto, OutSense also plans to conduct clinical trials in Israel and Japan.
Visit More News at Viga.cc News